Puretech Health PLC
PRTC | IL
Overview
Corporate Details
- ISIN(s):
- GB00BPVG5C82 (+2 more)
- LEI:
- 213800LVPDNO2Z9T9I39
- Country:
- United States of America
- Address:
- 6 TIDE STREET, 02210 BOSTON
- Website:
- https://www.puretechhealth.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Puretech Health PLC is a cutting-edge biotechnology company that is focused on developing and commercializing a wide range of innovative therapies in the healthcare industry. The company is based in the United Kingdom, and it has a growing presence in key markets around the world. Puretech Health is dedicated to leveraging the latest scientific advances to create transformative medicines that improve human health and wellness. The company works closely with leading researchers, academic institutions, and industry partners to develop novel approaches to treating a wide range of medical conditions.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-13 18:12 |
Regulatory News Service
PRTC's Vedanta Announces VE202 Phase 2 Results
|
English | 23.1 KB | |
| 2025-08-12 13:00 |
Business and Financial Review
PRTC Launches Celea to Advance Ph3-Ready IPF Drug
|
English | 22.0 KB | |
| 2025-08-05 18:30 |
Major Shareholding Notification
Holding(s) in Company
|
English | 22.1 KB | |
| 2025-08-01 08:00 |
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
|
English | 9.8 KB | |
| 2025-07-17 13:05 |
Regulatory News Service
PRTC’s Seaport Begins Phase 2b Study in MDD
|
English | 27.4 KB | |
| 2025-07-16 08:00 |
Board/Management Information
PureTech Announces Leadership Transition
|
English | 13.9 KB | |
| 2025-07-04 18:30 |
Director's Dealing
PDMR Notification
|
English | 22.3 KB | |
| 2025-07-04 18:30 |
Director's Dealing
PDMR Notification RSU Vesting
|
English | 24.5 KB | |
| 2025-07-04 18:30 |
Remuneration Information
PDMR Notification RSU Vesting
|
English | 24.0 KB | |
| 2025-06-16 18:27 |
Post-Annual General Meeting Information
Result of AGM
|
English | 32.0 KB | |
| 2025-05-29 18:30 |
Major Shareholding Notification
Holding(s) in Company
|
English | 25.0 KB | |
| 2025-04-30 16:27 |
Proxy Solicitation & Information Statement
Proxy Form for 2025 AGM
|
English | 219.2 KB | |
| 2025-04-30 16:23 |
Pre-Annual General Meeting Information
Notice of Meeting for 2025 AGM
|
English | 202.0 KB | |
| 2025-04-30 16:09 |
Annual Report (ESEF)
Annual Report and Accounts 2024
|
English | 21.4 MB | |
| 2025-04-30 16:09 |
Annual Report
Annual Report and Accounts 2024
|
English | 37.1 MB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ANIMALCARE GROUP PLC | United Kingdom | ANCR | |
|
Annexin Pharmaceuticals AB | Sweden | ANNX | |
|
Apontis Pharma AG | Germany | APPH | |
|
Aptahem AB | Sweden | APTA | |
|
Arctic Bioscience | Norway | ABS | |
|
ArcticZymes Technologies | Norway | AZT | |
|
argenx SE | Netherlands (Kingdom of the) | 1AE | |
|
ARIX BIOSCIENCE PLC | United Kingdom | ARIX | |
|
AroCell AB | Sweden | AROC | |
|
Arterra Bioscience | Italy | ABS |